Cambridge GenetiX was founded in Cambridge United Kingdom with a mission to redefine the development and delivery of advanced biologics, cell therapies, and gene therapies. Built on scientific foundations shaped in the laboratory of a Nobel Prize winning scientist and a legacy of creating transformative biotechnology companies, we are committed to delivering innovation and quality to patients worldwide. Located at the Cambridge Biomedical Campus alongside global leaders such as AstraZeneca, we operate within one of the world’s most dynamic life sciences ecosystems. By integrating cutting edge engineering, advanced manufacturing, and deep scientific expertise, Cambridge GenetiX develops accessible, scalable, and clinically meaningful therapies that bridge breakthrough science with real world patient needs.